↓ Skip to main content

Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia

Overview of attention for article published in Trials, June 2022
Altmetric Badge

Mentioned by

twitter
6 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
54 Mendeley